Jin Ding

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Prostate Cancer

Epithelial Mesenchymal Transition

Top Venues

Pharmaceutical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Jin Ding, Baowei Lu, Lumei Liu, Zixuan Zhong, Neng Wang, Bonan Li, Wen Sheng, Qinghu He
Guilu-Erxian-Glue alleviates Tripterygium wilfordii polyglycoside-induced oligoasthenospermia in rats by resisting ferroptosis via the Keap1/Nrf2/GPX4 signaling pathway. Pharmaceutical biology 61 (1) (2023)
Jin Ding, Baowei Lu, Lumei Liu, Zixuan Zhong, Neng Wang, Bonan Li, Wen Sheng, Qinghu He
Guilu-Erxian-Glue alleviates Tripterygium wilfordii polyglycoside-induced oligoasthenospermia in rats by resisting ferroptosis via the Keap1/Nrf2/GPX4 signaling pathway. Pharmaceutical biology 61 (1) (2023)
Jin Ding, Baowei Lu, Lumei Liu, Zixuan Zhong, Neng Wang, Bonan Li, Wen Sheng, Qinghu He
Guilu-Erxian-Glue alleviates Tripterygium wilfordii polyglycoside-induced oligoasthenospermia in rats by resisting ferroptosis via the Keap1/Nrf2/GPX4 signaling pathway. Pharmaceutical biology 61 (1) (2023)
Wei Fu, Jin Ding, Xujun You, Qixin Li, Xiaohua Pei, Guozheng Qin
Four types of RNA modification writers predict the prognosis of prostate cancer. Andrologia 54 (10) (2022)